Icu Medical Inc

Organisation

951 Calle Amanecer, San Clemente, CA, United States, 92673

Headquarters

13000

Employees

Health Technology

Industry

Vivek Jain

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Price

Target

Icu Medical Inc (ICUI) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Icu Medical Inc (ICUI) share price will touch around $182.67 in next 12-months.

Currently 10 wall-street analysts regularly analyze the financials of Icu Medical Inc on a frequent basis to provide recommendations along with target share price. 10 analysts offering 12-month price forecasts for Icu Medical Inc (ICUI) have a share price target of $182.67. This median of share price forecast represents a 45.92% upside from the latest price of $125.18 as on 20.03.26.

Icu Medical Inc (ICUI) Share Price Forecast

Home

US Stocks

Icu Medical Inc (ICUI)

Icu Medical Inc Stock Forecast

Icu Medical Inc Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Icu Medical Inc (ICUI): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Icu Medical Inc's share price and its median forecast price. As on 20.03.26, the difference is -19.14%

Icu Medical Inc Forecast and Target Price

Icu Medical Inc (ICUI) Share Price Forecast

Icu Medical Inc (ICUI) Price vs Consensus Price Target

Icu Medical Inc (ICUI) Share Price Forecast v/s Share Price Today

Icu Medical Inc (ICUI): Difference between Current Price & Median Forecasted Price

Icu Medical Inc (ICUI) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price